Skip to main content
. 2018 Apr 20;50(4):38. doi: 10.1038/s12276-018-0053-x

Fig. 4. LJ-2698 prevented kidney injury in db/db mice.

Fig. 4

LJ-2698 (10 mg/kg) was administered in db/db mice and age-matched control db/m mice for 12 weeks. Losartan (1.5 mg/kg) was administered in diabetic mice to compare with the effect of LJ-2698. After 12 weeks of treatment, urine and plasma were collected for analysis of (a) urinary albumin, (b) plasma cystatin C, and (c) urinary KIM-1. Paraffin-embedded kidney sections were stained with (d) PAS staining and (e) nephrin antibody. The scale bar indicates 10 μm, original magnification was ×630. Quantitative analysis of (f) glomerular volume, (g) FMA, and (h) glomerular nephrin area are depicted. Data are presented as the mean ± SE of 7–10 mice/group. *p < 0.05 vs. db/m and p < 0.05 vs. db/db mice